Prudential plc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Sell
42,070
-5,700
-12% -$167K 0.01% 461
2025
Q4
$1.38M Buy
47,770
+12,500
+35% +$375K 0.01% 438
2025
Q3
$979K Sell
35,270
-101,200
-74% -$2.56M 0.01% 482
2025
Q2
$3.32M Sell
136,470
-45,200
-25% -$990K 0.02% 330
2025
Q1
$3.77M Buy
181,670
+21,300
+13% +$535K 0.02% 313
2024
Q4
$3.78M Buy
160,370
+15,200
+10% +$374K 0.02% 289
2024
Q3
$3.72M Buy
145,170
+5,000
+4% +$127K 0.02% 301
2024
Q2
$3.33M Buy
140,170
+18,300
+15% +$462K 0.02% 321
2024
Q1
$3.5M Sell
121,870
-3,900
-3% -$117K 0.03% 314
2023
Q4
$4.31M Buy
125,770
+8,400
+7% +$228K 0.04% 269
2023
Q3
$3.27M Sell
117,370
-6,200
-5% -$203K 0.04% 281
2023
Q2
$4.17M Sell
123,570
-8,600
-7% -$270K 0.05% 243
2023
Q1
$3.79M Hold
132,170
0.04% 246
2022
Q4
$3.73M Sell
132,170
-5,000
-4% -$159K 0.05% 247
2022
Q3
$4.51M Sell
137,170
-8,700
-6% -$319K 0.07% 179
2022
Q2
$4.69M Buy
145,870
+8,000
+6% +$280K 0.09% 163
2022
Q1
$6.45M Buy
137,870
+6,570
+5% +$313K 0.09% 124
2021
Q4
$8.17M Buy
131,300
+10,700
+9% +$740K 0.11% 84
2021
Q3
$8.91M Buy
120,600
+300
+0.2% +$25.2K 0.12% 74
2021
Q2
$11.1M Buy
120,300
+22,100
+23% +$1.88M 0.1% 133
2021
Q1
$8.71M Buy
+98,200
New +$9.74M 0.06% 253
2020
Q4
Sell
-44,950
Closed -$2.86M 608
2020
Q3
$2.86M Buy
44,950
+16,400
+57% +$961K 0.01% 330
2020
Q2
$1.49M Buy
+28,550
New +$1.22M 0.01% 365

Other funds holding ARKG

Prudential plc's ARKG Position: Q1 2026 in Review

Prudential plc reduced its ARK Genomic Revolution ETF (ARKG) stake by 12% in Q1 2026, selling an estimated $167K and leaving 42,070 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #461.

Prudential plc first reported a position in ARKG in Q2 2020 and has held it in 23 quarters since. The position peaked at $11.1M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Prudential plc held 42,070 shares of ARK Genomic Revolution ETF worth $1.11M as of Q1 2026.
  • Prudential plc sold 5,700 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $167K.
  • ARK Genomic Revolution ETF made up 0.01% of Prudential plc's portfolio in Q1 2026, its #461 holding.
  • Prudential plc first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 23 quarters since.
  • Prudential plc's ARK Genomic Revolution ETF position peaked at $11.1M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.